13F-HR 1 w11764e13fvhr.txt FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: June 30, 2005 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: [28-6964] The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger Title: SIGNING AUTHORITY ----------------- Phone: 41 (01) 267 67 00 Signature, Place, and Date of Signing: /s/ Adrian Bruengger ----------------------------------------- Schaffhausen, Switzerland, August 8, 2005 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus N.V. Biotech Invest N.V. Biotech Target N.V. Biotech Growth N.V. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 14 Form 13F Information Table Value Total: $1,296,816 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V. BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- -------- -------- -------- -------- -------- -------- -------- TITLE VALUE SHS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- -------- ----- -------- ------- --- ---- ---------- -------- ---- ------ ---- Amgen Inc. COM 031162100 63,483 1,050,000 SH DEFINED 1 1,050,000 NONE NONE Auxilium Pharmaceuticals, Inc. COM 05334D107 3,816 800,000 SH DEFINED 4 800,000 NONE NONE Biogen Idec Inc. COM 09062X103 108,724 3,156,000 SH DEFINED 1 3,156,000 NONE NONE Celgene Corporation COM 151020104 197,395 4,850,000 SH DEFINED 2 4,850,000 NONE NONE Elan Corporation, plc COM 284131208 13,640 2,000,000 SH DEFINED 2 2,000,000 NONE NONE Genentech COM 368710406 148,518 1,850,000 SH DEFINED 1 1,850,000 NONE NONE Genzyme Corporation COM 372917104 95,603 1,591,000 SH DEFINED 1 1,591,000 NONE NONE Gilead Sciences, Inc. COM 375558103 259,933 5,908,900 SH DEFINED 1 5,908,900 NONE NONE ICOS Corporation COM 449295104 11,644 550,000 SH DEFINED 3 550,000 NONE NONE Incyte Corporation COM 45337C102 21,450 3,000,000 SH DEFINED 3 3,000,000 NONE NONE OSI Pharmaceuticals COM 671040103 72,019 1,762,142 SH DEFINED 2 1,762,142 NONE NONE Sepracor Inc. COM 817315104 164,193 2,736,100 SH DEFINED 1 2,736,100 NONE NONE The Medicines Company COM 584688105 106,948 4,584,152 SH DEFINED 3 4,584,152 NONE NONE Theravance COM 88338T104 29,450 1,732,367 SH DEFINED 4 1,732,367 NONE NONE